Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene

Pharmacopsychiatry

Volumn 38, Issue 4, 2005, Pages 166-170

  Rybakowski, Janusz K ^a   Suwalska, A ^a   Skibinska, M ^a   Szczepankiewicz, A ^a   Leszczynska Rodziewicz, A ^a   Permoda, A ^a   Czerski, P M ^a   Hauser, J ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LITHIUM;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG RESPONSE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; AGED; ALLELES; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; GENOTYPE; HUMANS; LITHIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 23044442183     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-871239     Document Type: Article

References (32)

1. Angelucci F, Aloe L, Jiménez-Vasquez P, Mathé AA. Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in rat model of depression. Int J Neuropsychopharmacol 2003; 6: 225-231
2. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 1999; 22: 231-238
3. Egan M, Kojima M, Callicot JH, Goldberg TE, Kolachana BS, Bertolino A et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-269
4. Fukumoto T, Morinobu S, Okamoto Y, Kahaya A, Yamawaki S. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology 2001; 158: 100-106
5. Geller B, Badner JA, Tillman R, Christian SL, Bolhofner K, Cook EH Jr. Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2004; 161: 1698-1700
6. Hashimoto R, Takei N, Shimazu K, Christ L, Lu B, Chuang DM. Lithium induces brain-derived neurotrophic factor and activities TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate neurotoxicity. Neuropharmacology 2002; 43: 1173-1179
7. Hashimoto K, Shimizu E, Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 2004; 45: 104-114
8. Holoubek G, Noldner M, Treiber K, Muller WE. Effect of chronic antidepressant treatment on beta-receptor coupled signal transduction cascade. Which effect matters most? Pharmacopsychiatry 2004; 37 (Suppl 2):S113-119
9. Hong CJ, Huo SJ, Yen FC, Tung CL, Pan GM, Tsai SJ. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 2003; 48: 86-189
10. Jacobsen JP, Mork A. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain Res 2004; 1024: 183-192
11. Kunugi H, Ueki M, Otsuga M, Isse K, Hirasawa H, Kato N et al. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol Psychiatry 2001; 6: 83-86
12. Kunugi H, Iijima Y, Tatsumi M, Yoshida M, Hashimoto R, Kato T et al. No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study. Biol Psychiatry 2004; 56: 376-378
13. Lu B. BDNF and activity-dependent synaptic modulation. Learn Mem 2003; 10: 86-98
14. Manji HK, Zarate CA. Molecular and cellular mechanism underlying mood stabilization in bipolar disorder: implications for the development of improved therapeutics. Mol Psychiatry 2002; 7: S1S7
15. Miller SA, Dykaes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988; 16: 1215
16. Nakata K, Ujike H, Sakai A, Uchida N, Nomura A, Imamura T et al. Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett 2003; 337: 17-20
17. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. The brain-derived neurotropic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2002; 71: 651-655
18. Oswald P, Del-Favero J, Massat I, Souery D, Claes S, Van Broeckhoven C et al. Non-replication of the brain-derived neurotrophic factor (BDNF) association in bipolar affective disorder: a Belgian patient-control study. Am J Med Genet 2004; 1296: 34-35
19. Proschel M, Saunders A, Roses AD, Muller CR. Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic factor (BDNF). Hum Mol Genet 1992; 1: 353
20. Rowe MK, Chuang DM. Lithium neuroprotection: molecular mechanisms and clinical implications. Expert Rev Mol Med 2004; 6: 1-18
21. Rybakowski JK, Borkowska A, Czerski PM, Skibinska M, Hauser J. Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord 2003; 5: 468-472
22. Rybakowski JK, Suwalska A, Czerski PM, Dmitrzak-Weglarz M, Leszczynska-Rodziewicz A, Hauser J. Prophylactic effect of lithium in bipolar affective illness may be related to serotonin transporter genotype. Pol J Pharmacol, 2004: (in press)
23. Serretti A, Lilli R, Mandelli L, Lorenzi C, Smeraldi E. Serotonin transporter gene associated with lithium prophylaxis in mood disorders. Pharmacogenomics J 2001; 1: 71-77
24. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 1997; 56: 131-137
25. Skibinska M, Hauser J, Czerski PM, Leszczyńska-Rodziewicz A, Kosmowska M, Kapelski P et al. Association analysis of brain-derived neurotrophic factor (BDNF) gene ValGGMet polymorphism in schizophrenia and bipolar affective disorder. World J Biol Psychiatry 2004; 5: 215-220
26. Sklar P, Gabriel SB, McInnis MG, Bennet P, Lim YM, Tsan G et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. MoI Psychiatry 2002; 7: 579-593
27. Strauss J, Barr CL, George CJ, King N, Shaikh S, Devlin B et al. Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder. Am J Med Genet. 2004; 131B: 16-19
28. Szczepankiewicz A, Skibinska M, Czerski PM, Kapelski P, Leszczynska-Rodziewicz A, Slopien A et al. No association of the Brain-Derived Neurotrophic Factor (BDNF) gene C-270T polymorphism with schizophrenia. Schizophr Res, 2005: (in press)
29. Tsai S-J, Hong C-J, Yu YW-Y, Chen T-J. Association study of a brain-derived neurotrophic factor (BDNF) Val66met polymorphism and personality trait and intelligence in healthy young females. Neuropsychobiol 2004; 49: 13-16
30. Turecki G, Grof P, Grof E, D'Souza V, Lebuis L, Marineau C et al. Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium. Mol Psychiatry 2001; 6: 570-578
31. Tyler WJ, Alonso M, Bramham CR, Pozzo-Miller LD. From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem 2002; 9: 224-237
32. Yamada K, Mizuno M, Nabeshima T. Role for brain-derived neurotrophic factor in learning and memory. Life Sci 2002; 70: 735-744